ULTI_1170x120_3-2-21

Roche

Ten top BioPharma companies announce formation of Accumulus Synergy to develop global data sharing platform

Ten top BioPharma companies announce formation of Accumulus Synergy to develop global data sharing platform

BURLINGAME, Calif. — Ten of the world’s leading biopharmaceutical companies announced the formation of a new non-profit corporation, Accumulus Synergy, which is intended to support interactions between industry and health authorities worldwide to enable real-time collaboration and data exchange, as well as data submission. Accumulus Synergy was formed on July 13, 2020, to develop a

Roche to test Actemra in coronavirus patients

Roche to test Actemra in coronavirus patients

BASEL — Roche announced  Thursday that the company is working with the Food & Drug Administration (FDA) to initiate a randomised, double-blind, placebo-controlled Phase III clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), a part of the U.S. Health and Human Services Office of the Assistant Secretary for Preparedness and

Roche to buy diabetes app provider mySugr

Roche to buy diabetes app provider mySugr

BASEL, Switzerland — Roche has entered an agreement to acquire mySugr GmbH, a Vienna-based provider of diabetes management apps and services. The drug maker said mySugr’s leading mobile diabetes platform, with more than 1 million users globally, will become a linchpin of its new patient-centered digital health services platform in diabetes care. Founded in 2012

Concerns about Zika threat on the rise in this country

WASHINGTON — A new study suggests that the Zika virus can live and cause damage in newborns for at least two months after birth, raising new concerns among health officials across the globe. The report, published online in the New England Journal of Medicine, involves a baby boy born in January to a woman in